Luzitin
PrivateLast Round
Growth Equity
Dec 19, 2023
Total Funding Raised
$32.84M
Company Overview
Luzitin is a drug discovery company that develops innovative photosensitizing compounds intended for photodynamic therapy and photo diagnosis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Luzitin Comparables
Compare Luzitin with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| biolitec Holding GmbH & Co KG | 80% | |
| ImPact Biotech | 78% | |
| Theralase Technologies Inc. | 78% | |
Luzitin Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Dec 19, 2023 | ||||
| Seed | Oct 7, 2010 |
Key People
Founding team and executive leadership
Luzitin Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| InovCapital | Seed |
| C2 Capital Partners | Growth Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 7, 2026
Monthly visitors increased 108% MoM, reaching 9.3K.
- Jul 2, 2025
Monthly visitors grew 72% MoM, reaching 5K.
Luzitin Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Luzitin's valuation, stock price, and market status.